Steven Roblin

Steven Roblin is a seasoned medical professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Medical Director at Alnylam Pharmaceuticals since November 2018, Steven has previously held roles including Medical Director and Medical Lead for Canada. Before joining Alnylam, Steven worked at Grifols for over a decade, advancing from Scientific Development Manager to Director of Medical Affairs, where responsibilities included leading medical initiatives and strategic direction across various therapeutic areas. Steven's career began as a Research Scientist at the Hospital for Sick Children. Steven holds a PhD in Pharmacology and Toxicology from the University of Toronto and a B.Sc.H in Life Sciences from Queen's University.